Rusfertide Shows Promise in Polycythemia Vera – Renal and Urology News
Researchers sought to determine whether rusfertide would be effective in patients with polycythemia vera.
Researchers sought to determine whether rusfertide would be effective in patients with polycythemia vera.
The FDA has approved Voquezna (vonoprazan) for heartburn associated with nonerosive gastroesophageal reflux disease.
Out-of-pocket costs for type 2 diabetes drugs increase as patients age into Medicare.
Global regional differences seen in patient characteristics, treatment, and outcomes
Introduction:The AUA convened a 2021-2022 Quality Improvement Summit to bring together interdisciplinary providers to inform the current state and to discuss potential strategies for integrating…
“This highlights a need for physicians to better integrate patient preferences into their treatment recommendations,” says Jonathan Bergman, MD, MPH.
(HealthDay News) — Hospitals and clinical laboratories across the United States are facing a critical shortage of bottles used to culture blood samples, federal health…
“Our goal is to support patients throughout their entire journey with an intelligence chat system that not only evaluates them, but also answers many questions…
The European Association of Urology (EAU) Neuro-Urology Guidelines aim to provide information for clinical practitioners on the incidence, definitions, diagnosis, therapy, and follow-up of neuro-urological…
Physicians need to consider a number of factors when deciding whether to agree to patients’ requests for wellness infusions.
“Stones that recur in children happen about 40% to 50% of the time. That’s why the American Urological Association guidelines recommend doing a complete metabolic…